Codiak BioSciences, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Codiak BioSciences, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2022.
  • Codiak BioSciences, Inc. Return On Equity for the quarter ending September 30, 2022 was -37.6 %, a 77.8% increase year-over-year.
  • Codiak BioSciences, Inc. annual Return On Equity for 2021 was -71.4 %, a 238% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -37.6 +132 +77.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -44 -299 -117% Apr 1, 2022 Jun 30, 2022
Q1 2022 -74.3 -150 -198% Jan 1, 2022 Mar 31, 2022
Q4 2021 -71.4 -123 -238% Oct 1, 2021 Dec 31, 2021
Q3 2021 -170 Jul 1, 2021 Sep 30, 2021
Q2 2021 255 Apr 1, 2021 Jun 30, 2021
Q1 2021 75.6 Jan 1, 2021 Mar 31, 2021
Q4 2020 51.9 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.